APA

Fanouriakis A., Papalopoulos I., Gergianaki I., Spyrou G., Erden A., Rapsomaniki P., Terizaki M., Avgoustidis N., Repa A., Kougkas N., Bertsias G., Boumpas D. T. & Sidiropoulos P. I. (20190107). In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. : Clinical and experimental rheumatology.

Chicago

Fanouriakis Antonis, Papalopoulos Ioannis, Gergianaki Irini, Spyrou Giorgis, Erden Abdulsamet, Rapsomaniki Panagiota, Terizaki Maria, Avgoustidis Nestor, Repa Argyro, Kougkas Nikolaos, Bertsias George, Boumpas Dimitrios T and Sidiropoulos Prodromos I. 20190107. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. : Clinical and experimental rheumatology.

Harvard

Fanouriakis A., Papalopoulos I., Gergianaki I., Spyrou G., Erden A., Rapsomaniki P., Terizaki M., Avgoustidis N., Repa A., Kougkas N., Bertsias G., Boumpas D. T. and Sidiropoulos P. I. (20190107). In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. : Clinical and experimental rheumatology.

MLA

Fanouriakis Antonis, Papalopoulos Ioannis, Gergianaki Irini, Spyrou Giorgis, Erden Abdulsamet, Rapsomaniki Panagiota, Terizaki Maria, Avgoustidis Nestor, Repa Argyro, Kougkas Nikolaos, Bertsias George, Boumpas Dimitrios T and Sidiropoulos Prodromos I. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. : Clinical and experimental rheumatology. 20190107.